Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
1 Growth Stock That'll Beat Amazon and 1 That Probably Won't (for Now)
06:40am, Tuesday, 04'th Oct 2022
The two companies are collaborators, but they aren't equally likely to be a better purchase than Amazon.
2 Top Biotech Stocks to Buy for the Long Haul
10:00am, Sunday, 02'nd Oct 2022
Both drugmakers have outperformed the stock market this year.
CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and Therapy
08:00am, Thursday, 29'th Sep 2022
ZUG, Switzerland and BOSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dise
Why Is Crispr Therapeutics (CRSP) Stock Up Today?
10:53am, Tuesday, 27'th Sep 2022
Source: rafapress / Shutterstock.com Crispr Therapeutics (NASDAQ: CRSP ) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review. That rolling review star
CRISPR, Vertex say FDA granted rolling review to experimental CRISPR therapy
09:38am, Tuesday, 27'th Sep 2022
CRISPR Therapeutics Inc. CRSP, +7.21% and Vertex Pharmaceuticals Inc. VRTX, +3.04% said Tuesday that the Food and Drug Administration granted a rolling review to the exagamglogene autotemcel, the ther
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
08:00am, Saturday, 24'th Sep 2022
S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market. The post S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market appeared fi
Recession Fears Increasing: Here's the Best Stock to Buy Right Now
05:52am, Saturday, 24'th Sep 2022
There's a lot to like about this high-flying stock.
Crispr: Elucidating And Forecasting Key Developments
04:54am, Wednesday, 21'st Sep 2022
In collaboration with stellar partners like Vertex, Crispr is aggressively expanding its robust pipeline of gene-edited medicine for various disorders. By year end, Crispr is poised to file a marketin
The 7 Best Biotech Stocks to Buy
01:45pm, Tuesday, 20'th Sep 2022
I've written before about how biotech is the biggest technology trend of our kids' generation. Naturally, that means many people are looking for the best biotech stocks to buy.
2 Biotech Stocks That Could Make You Richer
10:07am, Saturday, 17'th Sep 2022
Both have performed better than the broader market this year, but one stands out in this category.
Intellia's stock is up 6% on data from an early-stage trial for its Crispr therapy
08:38am, Friday, 16'th Sep 2022
Shares of Intellia Therapeutics Inc. NTLA, +7.36% gained 6.5% in premarket trading on Friday after the company and Regeneron Pharmaceuticals Inc. REGN, +1.18% announced positive data from an ongoing P
If You've Got $5,000, Buying These 5 Top Stocks Right Now Would Be a Genius Move
07:16am, Thursday, 15'th Sep 2022
These stocks have what it takes to deliver lasting gains down the road.
CRISPR Therapeutics AG (CRSP) Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
05:59pm, Monday, 12'th Sep 2022
CRISPR Therapeutics AG (NASDAQ:CRSP ) Morgan Stanley 20th Annual Global Healthcare Conference Call September 12, 2022 11:40 AM ET Company Participants Samarth Kulkarni - Chief Executive Officer Confer
Crispr Therapeutics: Nearing Harvest Season
02:19pm, Thursday, 08'th Sep 2022
Crispr Therapeutics is continuing to show strong execution. An announcement of the information release of discussions surrounding the CTX001 filing is expected in weeks.
CRISPR Therapeutics AG (CRSP) Citi 17th Annual BioPharma Conference Transcript
02:29pm, Wednesday, 07'th Sep 2022
CRISPR Therapeutics AG (NASDAQ:CRSP ) Citi 17th Annual BioPharma Conference September 7, 2022 8:50 AM ET Company Participants Sam Kulkarni – Chief Executive Officer Conference Call Participants Yiga
